Patent details

300799 Product Name: Efmoroctocog alfa

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300799
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1625209
Status:
SPC in force
Application number:
300799
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)

Paediatric Extension

SPC Extension Filing Date:
12/05/2020
SPC Extension Agent/Owner Name:
Bioverativ Therapeutics Inc. , ir. F.A. Geurts c.s.
SPC Extension Status:
Extension Granted
SPC Extension Grant Date:
13/05/2020
SPC Extension Request Refusal Date:
SPC Extension Revocation Date:

Marketing Authorization

Marketing Authorization Number:
EU/1/15/1046
Marketing Authorization Type:
EEA
Marketing Authorization Date:
23/11/2015
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
09/03/2016
First Marketing Authorization date:
23/11/2015
Grant date:
01/09/2016
Activation date:
06/05/2024
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
11/04/2016
SPC/SPC Extension Expiration Date:
05/11/2029
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
16/11/2017
 
 

 

Name:
Bioverativ Therapeutics Inc.
Address:
225 Second Avenue, 02451, Waltham, MA, United States of America (US)

Historical Applicant/holder

From:
16/11/2017
To:
16/11/2017

 

Name:
Bioverativ Therapeutics Inc.
Address:
225 Second Avenue, 02451, Waltham, MA, United States of America (US)

From:
25/03/2016
To:
11/04/2017

 

Name:
BIOGEN HEMOPHILIA INC.
Address:
250 Binney Street, 02451, Cambridge, MA 02142, United States of America (US)

Agent

Name:
ir. F.A. Geurts c.s.
From:
25/03/2016
Address:
Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC
Journal edition number:
19/24
Publication date:
08/05/2024
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

2

Bulletin Heading:
SPC
Journal edition number:
21/20
Publication date:
20/05/2020
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

3

Bulletin Heading:
SPC
Journal edition number:
21/20
Publication date:
20/05/2020
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

4

Bulletin Heading:
CO
Journal edition number:
25/17
Publication date:
21/06/2017
Description:
Changes in the Netherlands Patent Register

5

Bulletin Heading:
SPC
Journal edition number:
36/16
Publication date:
07/09/2016
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

6

Bulletin Heading:
SPC
Journal edition number:
15/16
Publication date:
13/04/2016
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Deed

Change of Address

Change Kind/ Decision Type:
Owner
Deed Number:
RC201702274A
Date Registered:
16/11/2017
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Change of owner(s) name
Deed Number:
RC201700883A
Date Registered:
11/04/2017
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Bioverativ Therapeutics Inc.
Address:
250 Binney Street, 02451, Cambridge, MA 02142, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Other

Note:

Annual Fee

Annual Fee(s) Due Date:
31/05/2026
Annual Fee Number:
23
Annual Fee Amount:
2000 Euro
Last Annual Payment Date:
22/04/2025
Last Annual Fee Paid Number:
22
Last Annual Fee Paid Amount:
1800 Euro
Payer:
Arnold & Siedsma BV
Filing date Document type Document Description Number of pages File Type
13/05/2020 SPC Documents Certificate SPC 1 PDF /6/0/3/6/3/0800036306/docs/300799_6_supplprotectioncertificate20200513025706305.pdf
13/05/2020 Outgoing Correspondence Confirmation receipt request for extension 1 PDF /6/0/3/6/3/0800036306/docs/300799_7_343975l505.pdf
13/05/2020 Outgoing Correspondence Decision extension duration 1 PDF /6/0/3/6/3/0800036306/docs/300799_16_344061l504c.pdf
12/05/2020 SPC Documents Summary of the characteristics of the product 18 PDF /6/0/3/6/3/0800036306/docs/300799_1_supplprotectioncertificate20200513110204358.pdf
12/05/2020 Application Form First filed application form 3 PDF /6/0/3/6/3/0800036306/docs/300799_5_applicationform20200513110204039.pdf
12/05/2020 SPC Documents Annex SPC 42 PDF /6/0/3/6/3/0800036306/docs/300799_10_supplprotectioncertificate20200513110204225.pdf
12/05/2020 SPC Documents Annex SPC 1 PDF /6/0/3/6/3/0800036306/docs/300799_11_supplprotectioncertificate20200513110204147.pdf
12/05/2020 SPC Documents Marketing Authorization SPC 3 PDF /6/0/3/6/3/0800036306/docs/300799_13_supplprotectioncertificate20200513110204308.pdf
12/05/2020 SPC Documents Mail SPC 72 PDF /6/0/3/6/3/0800036306/docs/300799_14_supplprotectioncertificate20200513112242647.pdf
12/05/2020 SPC Documents Annex SPC 1 PDF /6/0/3/6/3/0800036306/docs/300799_15_supplprotectioncertificate20200513110204416.pdf
01/09/2016 Outgoing Correspondence Outgoing Letter 1 PDF /6/0/3/6/3/0800036306/docs/300799_4_outgoingcorrespondence20160902042508959.pdf
01/09/2016 SPC Documents Certificate SPC 1 PDF /6/0/3/6/3/0800036306/docs/300799_17_supplprotectioncertificate20160902042509044.pdf
10/08/2016 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /6/0/3/6/3/0800036306/docs/300799_0_incomingcorrespondencepaper20160812091954437.pdf
26/05/2016 Outgoing Correspondence Outgoing Letter 2 PDF /6/0/3/6/3/0800036306/docs/300799_8_outgoingcorrespondence20160527020630577.pdf
11/04/2016 Outgoing Correspondence Outgoing Letter 1 PDF /6/0/3/6/3/0800036306/docs/300799_18_48136l174.pdf
09/03/2016 SPC Documents Summary of the characteristics of the product 18 PDF /6/0/3/6/3/0800036306/docs/300799_2_supplprotectioncertificate20210111035642622.pdf
09/03/2016 Application Form First filed application form 3 PDF /6/0/3/6/3/0800036306/docs/300799_3_applicationform20160315030006216.pdf
09/03/2016 SPC Documents Marketing Authorization SPC 3 PDF /6/0/3/6/3/0800036306/docs/300799_9_supplprotectioncertificate20160315030006516.pdf
09/03/2016 SPC Documents Annex SPC 1 PDF /6/0/3/6/3/0800036306/docs/300799_12_supplprotectioncertificate20200513112441761.pdf